Efecto de tres tipos de presas vivas en la larvicultura de bagre blanco (Sorubim cuspicaudus)

RESUMENObjetivo. Evaluar el efecto de diferentes presas vivas en la larvicultura de bagre blanco (Sorubim cuspicaudus). Materiales y métodos. Al inicio de la alimentación exógena de Sorubim cuspicaudus, se ofreció zooplancton producido en mesocosmos (T1), zooplancton silvestre (T2) y nauplios de Artemia (T3), en concentración de 10.000 zoop/L, dos veces al día, durante seis días. Se utilizaron 18 acuarios de cinco litros de volumen útil, con densidad de 25 Larvas/L, seis réplicas por tratamiento en un diseño al azar. Se estimaron la ganancia en peso (Gp) y longitud (Gl), tasa de crecimiento específico (G), sobrevivencia (S), resistencia al estrés (Re), mortalidad acumulada (Ma) y mortalidad por canibalismo (Mc). Resultados. Las larvas alimentadas con mesocosmos presentaron la mayor sobrevivencia (81.3±15.9%); aunque el mejor crecimiento lo presentaron las larvas alimentadas con zooplancton silvestre (T2) las cuales presentaron la mayor mortalidad (42.0±10.7%) y la menor resistencia al estrés (30.0±33.0%). El canibalismo se observó en todos los tratamientos, oscilando entre 4.0 (T2) y 14.3% (T1) sin diferencias significativas entre estos valores (p>0.05). Conclusiones. El uso de zooplancton producido bajo condiciones controladas permitió una alta sobrevivencia, adecuado desempeño y resistencia de las larvas, perfilándose como alternativa viable en la primera alimentación de bagre blanco

QUANTIFICATION OF RESIDUAL CLOVE OIL, BENZOCAINE AND TRICAINE IN FISH FILLETS USING SPE AND UPLC-DAD

Residual quantification of the anesthetics clove oil (CO) – isoeugenol (ISO), eugenol (EUG) and methyleugenol (MET) –,benzocaine (BZN) and tricaine (MS-222) was made in fillets of two fish species: Nile tilapia (Oreochromis niloticus) and acatfish hybrid, cachadia (Pseudoplatystoma reticulatum x Leiarius marmoratus). Samples (n=4) of each fish wereevaluated after submitted to anesthesia in five dosages defined based on the induction time of each species afterdepuration times (0h, 12h, 24h and 48h). Different methodologies of sample preparation were tested and selectedaccording to the better recovery. The quantification of anesthetics was performed by UPLC-DAD. The variance of residualmeans among anesthetics, dosages and fish species was compared. After anesthesia (0h) both species, tilapia andcachadia, presented residual anesthetics. Fishes depurated during 12h, 24h and 48h did not present detectable values, itmeans, values were below the limits of detection. BZN presented the highest mean residual concentration for tilapia andcachadia (p=0.01), while MS-222 presented the lowest residual amounts in tilapias and EUG in cachadias, what may berelated to the metabolism and carcass composition of each fish species. There were no significant differences among thefive dosages, except the lowest MS-222 concentration in tilapias that resulted in higher residual concentrations becauselow dosages increase the induction time and consequently the permanence of the fish in anesthesia. Ultimately, meanvalues of residues in cachadia were higher than in tilapia, and MS-222 and EUG presented the lowest residual values fortilapia and cachadia, respectively

Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital

OBJECTIVES: To prospectively evaluate demographic, anthropometric and health-related quality of life (HRQoL) in pediatric patients with laboratory-confirmed coronavirus disease 2019 (COVID-19) METHODS: This was a longitudinal observational study of surviving pediatric post-COVID-19 patients (n=53) and pediatric subjects without laboratory-confirmed COVID-19 included as controls (n=52) was performed. RESULTS: The median duration between COVID-19 diagnosis (n=53) and follow-up was 4.4 months (0.8-10.7). Twenty-three of 53 (43%) patients reported at least one persistent symptom at the longitudinal follow-up visit and 12/53 (23%) had long COVID-19, with at least one symptom lasting for >12 weeks. The most frequently reported symptoms at the longitudinal follow-up visit were headache (19%), severe recurrent headache (9%), tiredness (9%), dyspnea (8%), and concentration difficulty (4%). At the longitudinal follow-up visit, the frequencies of anemia (11% versus 0%, p=0.030), lymphopenia (42% versus 18%, p=0.020), C-reactive protein level of >30 mg/L (35% versus 0%, p=0.0001), and D-dimer level of >1000 ng/mL (43% versus 6%, p=0.0004) significantly reduced compared with baseline values. Chest X-ray abnormalities (11% versus 2%, p=0.178) and cardiac alterations on echocardiogram (33% versus 22%, p=0.462) were similar at both visits. Comparison of characteristic data between patients with COVID-19 at the longitudinal follow-up visit and controls showed similar age (p=0.962), proportion of male sex (p=0.907), ethnicity (p=0.566), family minimum monthly wage (p=0.664), body mass index (p=0.601), and pediatric pre-existing chronic conditions (p=1.000). The Pediatric Quality of Live Inventory 4.0 scores, median physical score (69 [0-100] versus 81 [34-100], p=0.012), and school score (60 [15-100] versus 70 [15-95], p=0.028) were significantly lower in pediatric patients with COVID-19 at the longitudinal follow-up visit than in controls. CONCLUSIONS: Pediatric patients with COVID-19 showed a longitudinal impact on HRQoL parameters, particularly in physical/school domains, reinforcing the need for a prospective multidisciplinary approach for these patients. These data highlight the importance of closer monitoring of children and adolescents by the clinical team after COVID-19